Direct supply of Covaxin to 18 states since May 1: Bharat Biotech

By: |
May 11, 2021 8:37 PM

The company is supplying its vaccine to Andhra Pradesh, Assam, Bihar, Chhattisgarh, Delhi, Gujarat, Haryana, Jammu & Kashmir, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Odisha, Tamil Nadu, Tripura, Telangana, Uttar Pradesh and West Bengal.

Bharat BiotechBharat Biotech has commenced direct supply of Covaxin with effect from May 1 to several states.

Bharat Biotech on Tuesday said it will continue the steady supply of its COVID-19 vaccine Covaxin, adding the jab has been directly supplied to 18 states since May 1.

The states include Andhra Pradesh, Delhi, Bihar, Gujarat, Haryana, Uttar Pradesh and West Bengal, the Hyderabad-based firm added.

“COVAXIN has been directly supplied to 18 states since May 1st. Unflinching in our efforts, we will continue the steady supply of our #vaccine,” Bharat Biotech said in a tweet.

The company is supplying its vaccine to Andhra Pradesh, Assam, Bihar, Chhattisgarh, Delhi, Gujarat, Haryana, Jammu & Kashmir, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Odisha, Tamil Nadu, Tripura, Telangana, Uttar Pradesh and West Bengal.

Bharat Biotech has commenced direct supply of Covaxin with effect from May 1 to several states based on the allocations received by the central government, the company’s Joint Managing Director Suchitra Ella had earlier said.

On April 29, Bharat Biotech had announced a cut in the price of Covaxin for states to Rs 400 per dose from the earlier Rs 600.

This followed widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose.

India has expanded its COVID-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Delta variant of coronavirus more transmissible, more dangerous, says US Surgeon General Dr Vivek Murthy
2Coronavirus pandemic: Centre classifies Delta Plus as variant of concern, issues advisory to affected states
3Mask compliance still remains low in India despite most lethal COVID-19 wave: Survey